Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.

Fulltext:
47552.pdf
Embargo:
until further notice
Size:
109.0Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2005Source
The Lancet (London), 365, 9470, (2005), pp. 1552-60ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pulmonary Diseases
General Practice
Journal title
The Lancet (London)
Volume
vol. 365
Issue
iss. 9470
Page start
p. 1552
Page end
p. 60
Subject
N4i 1: Pathogenesis and modulation of inflammation; UMCN 2.1: Heart, lung and circulationAbstract
BACKGROUND: Increased oxidative stress is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). We postulated that treatment with the antioxidant N-acetylcysteine would reduce the rate of lung-function decline, reduce yearly exacerbation rate, and improve outcomes. METHODS: In a randomised placebo-controlled study in 50 centres, 523 patients with COPD were randomly assigned to 600 mg daily N-acetylcysteine or placebo. Patients were followed for 3 years. Primary outcomes were yearly reduction in forced expiratory volume in 1 s (FEV1) and the number of exacerbations per year. Analysis was by intention to treat. FINDINGS: The yearly rate of decline in FEV1 did not differ between patients assigned N-acetylcysteine and those assigned placebo (54 mL [SE 6] vs 47 mL [6]; difference in slope between groups 8 mL [9]; 95% CI -25 to 10). The number of exacerbations per year did not differ between groups (1.25 [SD 1.35] vs 1.29 [SD 1.46]; hazard ratio 0.99 [95% CI 0.89-1.10, p=0.85]). Subgroup analysis suggested that the exacerbation rate might be reduced with N acetylcysteine in patients not treated with inhaled corticosteroids and secondary analysis was suggestive of an effect on hyperinflation. INTERPRETATION: N-acetylcysteine is ineffective at prevention of deterioration in lung function and prevention of exacerbations in patients with COPD.
This item appears in the following Collection(s)
- Academic publications [232208]
- Electronic publications [115401]
- Faculty of Medical Sciences [89084]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.